Association Between the T29→C Polymorphism in the Transforming Growth Factor β1 Gene and Breast Cancer Among Elderly White Women: The Study of Osteoporotic Fractures

• Published in: JAMA : the journal of the American Medical Association Vol. 285; no. 22; pp. 2859 - 2863
• Main Authors: Ziv, Elad, Cauley, Jane, Morin, Phillip A, Saiz, Robert, Browner, Warren S
• Format: Journal Article
• Language: English
• Published: American Medical Association 13.06.2001
• ISSN: 0098-7484; 1538-3598
• DOI: 10.1001/jama.285.22.2859

CONTEXT Transgenic animal experiments suggest that increased expression of transforming growth factor β1 (TGF-β1) is protective against early tumor development, particularly in breast cancer. A T→C (thymine to cytosine) transition in the 29th nucleotide in the coding sequence results in a leucine to proline substitution at the 10th amino acid and is associated with increased serum levels of TGF-β1. OBJECTIVE To determine whether an association exists between this TGF-β1 polymorphism and breast cancer risk. DESIGN, SETTING, AND PARTICIPANTS The Study of Osteoporotic Fractures, a prospective cohort study of white, community-dwelling women aged 65 years or older who were recruited at 4 US centers between 1986 and 1988. Three thousand seventy-five women who provided sufficient clinical information, buffy coat samples, and adequate consent for genotyping are included in this analysis. MAIN OUTCOME MEASURE Breast cancer cases during a mean (SD) follow-up of 9.3 (1.9) years, verified by medical chart review and compared by genotype. RESULTS Risk of breast cancer was similar in the 1124 women with the T/T genotype (56 cases; 5.4 per 1000 person-years) and the 1493 women with the T/C genotype (80 cases; 5.8 per 1000 person-years) but was significantly lower (P = .01) in the 458 women with the C/C genotype (10 cases; 2.3 per 1000 person-years). In analyses that adjusted for age, age at menarche, age at menopause, estrogen use, parity, body mass index, and bone mineral density, women with the C/C genotype had a significantly lower risk of developing breast cancer compared with women with the T/T or T/C genotype (hazard ratio [HR], 0.36; 95% confidence interval [CI], 0.17-0.75). There was no significant difference between the risk for women with the T/C genotype compared with women with the T/T genotype (adjusted HR, 1.04; 95% CI, 0.73-1.48). CONCLUSIONS Our findings suggest that TGF-β1 genotype is associated with risk of breast cancer in white women aged 65 years or older. Because the T allele is the common variant and confers an increased risk, it may be associated with a large proportion of breast cancer cases.